| Dr Emilie J Calvello Hynes, MD, MPH | |
|
12605 E 16th Ave, University Of Colorado Hospital, Aurora, CO 80045 | |
| (720) 848-0000 | |
| Not Available |
| Full Name | Dr Emilie J Calvello Hynes |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 12605 E 16th Ave, Aurora, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700923596 | NPI | - | NPPES |
| 417904800 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | DR.0054457 (Colorado) | Primary |
| 207P00000X | Emergency Medicine | 27837 (Nebraska) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Emilie J Calvello Hynes, MD, MPH Po Box 2995, Acp 13129, Annapolis, MD 21404 Ph: (443) 831-3160 | Dr Emilie J Calvello Hynes, MD, MPH 12605 E 16th Ave, University Of Colorado Hospital, Aurora, CO 80045 Ph: (720) 848-0000 |
News Archive
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported its financial results and business highlights for the first quarter ended March 31, 2010.
WHO and the Institute of Health Metrics and Evaluation today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges.
The National Institutes of Health has awarded a multimillion-dollar grant to further life sciences research at the University of Kansas and throughout Kansas. It is the largest grant ever awarded to a Kansas university.
Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, today announced a new study has been published identifying the mechanism of action of the anti-cancer drug GMX1778. Co-authored by scientists at Gemin X Pharmaceuticals and Metabolon, the paper "The Small Molecule GMX1778 is a Potent Inhibitor of NAD+ Biosynthesis: Strategy for Enhanced Therapy in NAPRT1-Deficient Tumors" appears online ahead of print in Molecular and Cellular Biology.
› Verified 4 days ago
Dr. Timothy Owen Vanderkooy, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, Co 80045-7106, Aurora, CO 80045 Phone: 720-777-1234 | |
Dr. Douglas K Hammond, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2550 S Parker Rd, Ste 206, Aurora, CO 80014 Phone: 303-306-7783 Fax: 303-306-7753 | |
Barbara Blok, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Charles Little, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Stephan Schrager, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Dr. William R Abbott, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3033 S Parker Rd, Ste 800, Aurora, CO 80014 Phone: 303-306-7783 Fax: 303-306-7753 | |
Michael Jobin, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |